(119 days)
The Deep Learning Image Reconstruction software is a deep learning based reconstruction method intended to produce cross-sectional images of the head and whole body by computer reconstruction of X-ray transmission data taken at different angles and planes, including Axial, Helical (Volumetric), and Cardiac acquisitions, for all ages. Deep Learning Image Reconstruction software can be used for head, whole body, cardiac, and vascular CT applications.
Deep Learning Image Reconstruction is an image reconstruction method that uses a dedicated Deep Neural Network (DNN) that has been designed and trained specifically to generate CT Images to give an image appearance, as shown on axial NPS plots, similar to traditional FBP images while maintaining the performance of ASiR-V in the following areas: dose, image noise (pixel standard deviation), low contrast detectability, high-contrast spatial resolution, and streak artifact suppression.
The images produced are branded as "TrueFidelity™ CT Images". Reconstruction times with Deep Learning Image Reconstruction software support a normal throughput for routine CT.
The deep learning technology is integrated into the scanner's existing raw data-based image reconstruction chain to produce DICOM compatible "TrueFidelity™ CT Images".
The system allows user selection of three strengths of Deep Learning Image Recon: Low, Medium or High. The strength selection will vary with individual users' preference for the specific clinical need.
The provided text is a 510(k) summary for the GE Healthcare Japan Corporation's "Deep Learning Image Reconstruction" device. It outlines the device's technical characteristics, intended use, and comparison to predicate devices for substantial equivalence determination. However, it does not include detailed information regarding specific acceptance criteria, a comprehensive study proving the device meets these criteria, or specific performance metrics in a tabular format. The document focuses on establishing substantial equivalence based on the fundamental technology being unchanged from the predicate and successful completion of design control testing and quality assurance measures.
Therefore, I cannot extract all the requested information. Here's what can be inferred and what is missing:
1. A table of acceptance criteria and the reported device performance
This information is not provided in the document. The document states: "Design verification and validation, including IQ bench testing, demonstrate that the Deep Learning Image Reconstruction (DLIR) software met all of its design requirement and performance criteria." However, it does not specify what those "design requirement and performance criteria" are or the reported performance data against them.
2. Sample sized used for the test set and the data provenance (e.g. country of origin of the data, retrospective or prospective)
This information is not provided in the document. The document mentions "IQ bench testing" and "System Testing" including "Image Performance Testing (Verification)" and "Simulating Use Testing (Validation)," but does not detail the sample sizes or data provenance used for these tests.
3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts (e.g. radiologist with 10 years of experience)
This information is not provided in the document.
4. Adjudication method (e.g. 2+1, 3+1, none) for the test set
This information is not provided in the document.
5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance
This information is not provided in the document. The document describes the device as a "deep learning based reconstruction method" that produces images with "similar to traditional FBP images while maintaining the performance of ASiR-V in the following areas: dose, image noise (pixel standard deviation), low contrast detectability, high-contrast spatial resolution, and streak artifact suppression." This implies a comparison to other reconstruction methods, but not a MRMC study involving human readers with and without AI assistance.
6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done
Yes, based on the description, the primary testing described is "standalone" algorithm performance. The device is a "deep learning based reconstruction method" and the testing described, such as "IQ bench testing" and "Image Performance Testing," focuses on the intrinsic image quality outputs of the algorithm. There is no mention of human-in-the-loop performance in the context of effectiveness studies.
7. The type of ground truth used (expert consensus, pathology, outcomes data, etc.)
This information is not explicitly stated in the document. Given the context of "IQ bench testing" and performance metrics like "image noise," "low contrast detectability," and "spatial resolution," it's highly likely that objective phantom studies and potentially established image quality metrics (which could be considered a form of "ground truth" for image quality, validated against known physical properties) were used. However, expert consensus on clinical diagnostic accuracy or pathology is not mentioned as a ground truth.
8. The sample size for the training set
This information is not provided in the document. It mentions that the device "uses a dedicated Deep Neural Network (DNN) that has been designed and trained specifically to generate CT Images," but the details of the training set are not disclosed.
9. How the ground truth for the training set was established
This information is not provided in the document. While it states the DNN was "trained specifically to generate CT Images to give an image appearance, as shown on axial NPS plots, similar to traditional FBP images while maintaining the performance of ASiR-V," the method for establishing the ground truth for this training is not detailed.
{0}------------------------------------------------
Image /page/0/Picture/0 description: The image contains the logos of the Department of Health & Human Services and the U.S. Food & Drug Administration (FDA). The Department of Health & Human Services logo is on the left, featuring a stylized design. To the right is the FDA logo, with the acronym "FDA" in a blue square, followed by the words "U.S. FOOD & DRUG" in a larger, bolder font, and "ADMINISTRATION" in a smaller font below.
July 29, 2022
GE Healthcare Japan Corporation % Wang Xing Regulatory Affairs Manager GE Hangwei Medical Systems Co., Ltd. West Area of Building No.3. No.1 Yongchang North Road Beijing Economic & Technological Development Area, Beijing 100176 CHINA
Re: K220961
Trade/Device Name: Deep Learning Image Reconstruction Regulation Number: 21 CFR 892.1750 Regulation Name: Computed tomography x-ray system Regulatory Class: Class II Product Code: JAK Dated: July 13, 2022 Received: July 14, 2022
Dear Wang Xing:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's
{1}------------------------------------------------
requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.
For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely,
Laurel Burk, Ph.D. Assistant Director DHT8B: Division of Imaging Devices and Electronic Products OHT8: Office of Radiological Health Office of Product Evaluation and Quality Center for Devices and Radiological Health
Enclosure
{2}------------------------------------------------
Indications for Use
510(k) Number (if known)
K220961
Device Name Deep Learning Image Reconstruction
Indications for Use (Describe)
The Deep Learning Image Reconstruction software is a deep learning based reconstruction method intended to produce cross-sectional images of the head and whole body by computer reconstruction of X-ray transmission data taken at different angles and planes, including Axial, (Volumetric), and Cardiac acquisitions, for all ages. Deep Learning Image Reconstruction software can be used for head, whole body, cardiac, and vascular CT applications.
| Type of Use (Select one or both, as applicable) | |
|---|---|
| Prescription Use (Part 21 CFR 801 Subpart D) | Over-The-Counter Use (21 CFR 801 Subpart C) |
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
{3}------------------------------------------------
Image /page/3/Picture/1 description: The image shows the logo for General Electric (GE). The logo is a blue circle with the letters "GE" in a stylized font in the center. There are decorative swirls around the letters. The logo is simple and recognizable, and it is associated with a well-known and established company.
510(k) SUMMARY
This 510(k) summary of Safety and Effectiveness information is submitted in accordance with the requirement of 21 CFR Part 807.87(h):
| Date: | March 31, 2022 |
|---|---|
| Submitter: | GE Healthcare Japan Corporation7-127, Asahigaoka, 4-chomeHino-shi, Tokyo, 191-8503, Japan |
| Primary Contact: | Wang XingRegulatory Affairs ManagerPhone +86 (10) 57388271Email: Xing1.wang@ge.com |
| Secondary Contacts: | Helen PengSenior Regulatory Affairs DirectorGE HealthcareTel: +1 (262) 4248222Email: hong.peng@med.ge.com |
| John JaeckleChief Regulatory Affairs StrategistGE HealthcareTel: +1 (262) 4249547Email: john.jaeckle@med.ge.com | |
| Device Trade Name: | Deep Learning Image Reconstruction |
| Device Classification | Class II |
| Regulation Number/ Product Code: | 21 CFR 892.1750 Computed tomography x-ray system /JAK |
| Predicate Device Information | |
| Device Name: | Deep Learning Image Reconstruction |
| Manufacturer: | GE Medical Systems, LLC |
| 510(k) Number: | K183202 cleared on April 12, 2019 |
| Regulation Number/ Product Code: | 21 CFR 892.1750 Computed tomography x-ray system /JAK |
| Reference Devices Information | |
| Device Name: | ASIR-V |
| Manufacturer: | GE Medical Systems, LLC |
| 510(k) Number: | K133640 cleared on March 25, 2014 |
| Regulation Number/ Product Code: | 21 CFR 892.1750 Computed tomography x-ray system /JAK |
| Device Name: | Discovery CT750 HD |
| Manufacturer: | GE Medical Systems, LLC |
| 510(k) Number: | K120833 cleared on June 13, 2012 |
| Regulation Number/ Product Code: | 21 CFR 892.1750 Computed tomography x-ray system /JAK |
{4}------------------------------------------------
Image /page/4/Picture/1 description: The image shows the General Electric (GE) logo. The logo consists of the letters "GE" in a stylized script, enclosed within a blue circle. There are decorative swirls around the letters, adding a touch of elegance to the design. The logo is simple, recognizable, and represents the General Electric brand.
Device Description
Deep Learning Image Reconstruction is an image reconstruction method that uses a dedicated Deep Neural Network (DNN) that has been designed and trained specifically to generate CT Images to give an image appearance, as shown on axial NPS plots, similar to traditional FBP images while maintaining the performance of ASiR-V in the following areas: dose, image noise (pixel standard deviation), low contrast detectability, high-contrast spatial resolution, and streak artifact suppression.
The images produced are branded as "TrueFidelity™ CT Images". Reconstruction times with Deep Learning Image Reconstruction software support a normal throughput for routine CT.
The deep learning technology is integrated into the scanner's existing raw data-based image reconstruction chain to produce DICOM compatible "TrueFidelity™ CT Images".
The system allows user selection of three strengths of Deep Learning Image Recon: Low, Medium or High. The strength selection will vary with individual users' preference for the specific clinical need.
DLIR has been cleared on GE's multiple CT systems of varying image chains, including Revolution CT systems (K133705, K163213, K19177), Revolution EVO (K131576) /Revolution Maxima (K192686) and Revolution Ascend (K201369). Now the DLR algorithm is being ported to Discovery CT750 HD family CT systems (K120833) which include Discovery CT750 HD, Revolution Frontier and Revolution Discovery CT, thus triggering this premarket notification.
Compared to the predicate device, the intended use and indications for use of Deep Learning Image Reconstruction are identical.
Intended Use
The Deep Learning Image Reconstruction software is intended for head, whole body, cardiac, and vascular CT scans.
{5}------------------------------------------------
Image /page/5/Picture/1 description: The image shows the logo for General Electric (GE). The logo is a blue circle with the letters "GE" in a stylized font in the center. There are four water droplet shapes surrounding the circle. The logo is simple and recognizable, and it is often used to represent the company's brand.
Indications for Use
The Deep Learning Image Reconstruction software is a deep learning based reconstruction method intended to produce cross-sectional images of the head and whole body by computer reconstruction of X-ray transmission data taken at different angles and planes, including Axial, Helical (Volumetric), and Cardiac acquisitions, for all ages.
Deep Learning Image Reconstruction software can be used for head, whole body, cardiac, and vascular CT applications.
Comparisons
The GE Deep Learning Image Reconstruction (DLIR) software for Discovery CT750 HD family CT systems, is substantially equivalent to the unmodified predicate device DLR reconstruction option (K183202) for Revolution CT family. The fundamental technology, i.e., the DLIR algorithm, remains unchanged from the predicate. The table below summarizes the substantive feature/technological differences between the predicate device and the proposed device:
| Specification/ Attribute | Deep Learning ImageReconstruction | Deep Learning ImageReconstruction |
|---|---|---|
| (Predicate Device, K183202) | (Proposed Device) | |
| Technology | Utilizes a dedicated Deep NeuralNetwork (DNN) designed specificallyto generate high quality CT images | Same |
| Clinical Workflow | Select recon type and strength (Low,Medium, High) | Same |
| Clinical Use | Routine Clinical Use | Same |
| Referenceprotocols/dose | Using the same Reference protocolsprovided on the Revolution CTfamily systems for ASiR-V | Using the same Reference protocolsprovided on the Discovery CT750HD family CT systems for ASiR-V |
| IQ performance vs dose | Image noise, low contrastdetectability, spatial resolution, andlow signal artifact suppression asgood or better than ASiR-V onRevolution CT family systems | Image noise, low contrastdetectability, spatial resolution, andlow signal artifact suppression asgood or better than ASiR-V onDiscovery CT750 HD family CTsystems |
| DeploymentEnvironment | On CT Console | On GE's Edison Platform. |
{6}------------------------------------------------
Image /page/6/Picture/1 description: The image shows the General Electric (GE) logo. The logo consists of the letters 'GE' written in a stylized script, enclosed within a circular frame. The logo is blue and the background is white.
Deep Learning Image Reconstruction on the Discovery CT750 HD family CT systems does not introduce any new risks/hazards, warnings, or limitations.
The changes described above do not change the fundamental control mechanism, operating principle, and do not change the intended use from the predicate device.
Determination of Substantial Equivalence
Summary of Performance Testing
Deep Learning Image Reconstruction has successfully completed the design control testing per our quality system. No additional hazards were identified, and no unexpected test results were observed. Deep Learning Image Reconstruction was designed under the Quality System Regulations of 21CFR 820 and ISO 13485. GE believes that the extensive software testing are sufficient for FDA's substantial equivalence determination.
The following quality assurance measures have been applied to the development of the software:
- Requirement Definition
- Risk Analysis and Control
- . Technical Design Reviews
- Formal Design Reviews
- Software Development Lifecycle
- o Code Review
- O Software Unit Implementation
- O Software Integrations and Integration Testing
- System Testing
- Safety Testing (Verification) O
- Image Performance Testing (Verification) O
- O Simulating Use Testing (Validation)
- Software Release
The testing and results did not raise different questions of safety and effectiveness than associated with predicate device. We consider the proposed device is substantially equivalent to the predicate device, DLIR for Revolution CT products.
The substantial equivalence is also based on the software documentation for a "Moderate" level of concern device.
Additionally, the same set of tests and test methods employed on the predicate DLIR for Revolution CT were reproduced to support substantial equivalence and the product performance claims of the subject device.
Substantial Equivalence
Deep Learning Image Reconstruction (DLIR) software for Discovery CT750 HD family CT systems was developed under GE Healthcare's quality system. The changes associated with Deep Learning Image Reconstruction (DLIR) do not change the Intended Use from the predicate, and represent equivalent technology characteristics, with no impact on control mechanism, operating principle, and energy type.
{7}------------------------------------------------
Image /page/7/Picture/1 description: The image shows the General Electric (GE) logo. The logo consists of the letters 'GE' intertwined in a stylized script, enclosed within a circle. Three water droplet-like shapes surround the circle, adding a decorative element to the design. The logo is presented in a blue color scheme.
Design verification and validation, including IQ bench testing, demonstrate that the Deep Learning Image Reconstruction (DLIR) software met all of its design requirement and performance criteria. Design control and risk management processes did not identify any new hazards, unexpected results, or adverse effects stemming from the changes to the predicate.
GE Healthcare believes that Deep Learning Image Reconstruction Software is substantially equivalent to the legally marketed predicate device and hence is safe and effective for its intended use.
§ 892.1750 Computed tomography x-ray system.
(a)
Identification. A computed tomography x-ray system is a diagnostic x-ray system intended to produce cross-sectional images of the body by computer reconstruction of x-ray transmission data from the same axial plane taken at different angles. This generic type of device may include signal analysis and display equipment, patient and equipment supports, component parts, and accessories.(b)
Classification. Class II.